최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기대한 두경부 종양 학회지 = Korean journal of head & neck oncology, v.22 no.2, 2006년, pp.130 - 136
김세헌 (연세대학교 의과대학 이비인후과학교실) , 최은창 (연세대학교 의과대학 이비인후과학교실) , 이진석 (연세대학교 의과대학 이비인후과학교실) , 천제영 (연세대학교 의과대학 이비인후과학교실) , 변형권 (연세대학교 의과대학 이비인후과학교실) , 송기재 (연세대학교 의과대학 이비인후과학교실) , 김광문 (연세대학교 의과대학 이비인후과학교실)
Introduction : The sensitivity of tumor cells to radiotherapy is a critical determinant of local control and potential cure in advanced head and neck squamous cell carcinoma(HNSCC). The emergence of radioresistant tumor cells is an obstacle to cancer therapy. Most radioresistant cells have a higher ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier JW, Hars Vl: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer N. Engl J Med. 1998;338:1798-1804
Girinsky T, Lubin R, Pignon JP, Chavaudra N, Gazeau J, Dubray B: Predictive value of in vitro radiosensitivity parameters in head and neck cancers and cervical carcinomas: preliminary correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 1993;25:147-148
West CM, Davidson SE, Roberts SA, Hunter RD: Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 1993;68:819-823
Kim SH, Carew JF, Kooby DA, et al: Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Ther. 2000;7:1279-1285
Kim SH, Wong RJ, Kooby DA, et al: Combination of mutated herpes simplex virus type 1 (G207 virus ) with radiation for the treatment of squamous cell carcinoma of the head and neck. Eur J Cancer. 2005;41 (2 ):313-322
Carew JF, Kooby DA, Halterman MW, Federoff HJ, Fong Y: Selective infection and cytolysis of human head and neck squamous cell carcinoma with sparing of normal mucosa by a cytotoxic herpes simplex virus type 1 (G207 ). Hum Gene Ther. 1999;10:1599-1606
Wong RJ, Kim SH, Joe JK, Shah JP, Johnson PA, Fong Y: Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus. J Am Coll Surg. 2001;193:12-21
Wong RJ, Joe JK, Kim SH, Shah JP, Horsburgh B, Fong Y: Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther. 2002;13:1213-1223
Mineta T, Rabkin SD, Yazaki T, Hunter WD, Martuza RL: Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Med. 1995;1:938-943
Kooby DA, Carew JF, Halterman MW, et al: Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herped simplex virus type-1 (G207 ). FASEB. 1999;13:1325-1334
Pearce AG, Segura TM, Rintala AC, Rintala-Maki ND, Lee H: The generation and characterization of a radiation-resistant model system to study radioresistance in human breast cancer cells. Radiate Res. 2001;156 (6 ):739-750
Lambin P, Malaise EP, Joiner MC: Might intrinsic radioresistance of human tumour cells be induced by radiation? Int J Radiat Biol. 1996;69 (3 ):279-290
Falck J, Petrini JH, Williams BR, Lukas J, Bartek J: The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nature Gen. 2002;30:290-294
Schang LM, Philips J, Schaffer PA: Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription. J Virol. 1998;72 (7 ):5626-5637
※ AI-Helper는 부적절한 답변을 할 수 있습니다.